[
  {
    "ts": null,
    "headline": "Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?",
    "summary": "Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.",
    "url": "https://finnhub.io/api/news?id=b140dbf79f8a9dcd441b6c26fba13f6ac796a3a6f3b118fd46b1ae6f23febcff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760618760,
      "headline": "Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?",
      "id": 137121983,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.",
      "url": "https://finnhub.io/api/news?id=b140dbf79f8a9dcd441b6c26fba13f6ac796a3a6f3b118fd46b1ae6f23febcff"
    }
  }
]